We are live on
!
Find out more
SR
Syntax Research Portfolio holdings
AUM
$157M
1-Year Est. Return
16.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
(-2.8%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.35M |
| 2 |
Zoetis
ZTS
|
+$2.21M |
| 3 |
Willis Towers Watson
WTW
|
+$2.17M |
| 4 |
Palo Alto Networks
PANW
|
+$2.16M |
| 5 |
Accenture
ACN
|
+$2.03M |
Top Sells
| 1 |
Nutrien
NTR
|
+$3.4M |
| 2 |
American Tower
AMT
|
+$3.32M |
| 3 |
Newmont
NEM
|
+$3.21M |
| 4 |
Americold
COLD
|
+$2.6M |
| 5 |
Merck
MRK
|
+$2.39M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 5.03% |
| 3 | Industrials | 4.92% |
| 4 | Financials | 4.5% |
| 5 | Materials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Eaton
ETN
$154B
| $80.3K | 0.06% |
225
| – | – |
|
77
Comcast
CMCSA
$86.1B
| $75K | 0.05% |
2,101
+7
| +0.3% | +$242 |
|
78
Darden Restaurants
DRI
$23B
| $73.5K | 0.05% |
337
| – | – |
|
79
Amgen
AMGN
$201B
| $66.2K | 0.05% |
237
| – | – |
|
80
Tesla
TSLA
$1.47T
| $65.1K | 0.05% |
205
-170
| -45% | -$51.2K |
|
81
Johnson & Johnson
JNJ
$602B
| $62.8K | 0.04% |
411
| – | – |
|
82
Walt Disney
DIS
$173B
| $59.1K | 0.04% |
477
| – | – |
|
83
Globus Medical
GMED
$11B
| $59K | 0.04% |
1,000
| – | – |
|
84
NextEra Energy
NEE
$186B
| $55.8K | 0.04% |
804
| – | – |
|
85
Caterpillar
CAT
$404B
| $52.4K | 0.04% |
135
| – | – |
|
|
86
American Tower
AMT
$78.7B
| $52K | 0.04% |
235
-15,355
| -98% | -$3.32M |
|
87
iShares US Financials ETF
IYF
$4.24B
| $48.9K | 0.03% |
404
| – | – |
|
88
HP
HPQ
$22.1B
| $46.4K | 0.03% |
1,897
| – | – |
|
89
Honeywell
HON
$71.7B
| $44.5K | 0.03% |
203
| – | – |
|
90
iShares Russell 2000 Growth ETF
IWO
$14.7B
| $41.7K | 0.03% |
146
| – | – |
|
91
Dow Inc
DOW
$21.1B
| $41.2K | 0.03% |
1,557
-76,495
| -98% | -$2.23M |
|
92
Hewlett Packard
HPE
$59.8B
| $38.8K | 0.03% |
1,897
| – | – |
|
93
Verizon
VZ
$183B
| $38.2K | 0.03% |
883
| – | – |
|
94
Emerson Electric
EMR
$77.9B
| $33.5K | 0.02% |
251
-3,588
| -93% | -$412K |
|
95
Kroger
KR
$35.9B
| $31.1K | 0.02% |
433
| – | – |
|
96
Vanguard Small-Cap ETF
VB
$79.7B
| $30.6K | 0.02% |
129
| – | – |
|
97
General Dynamics
GD
$99.7B
| $29.2K | 0.02% |
100
| – | – |
|
98
Schwab International Equity ETF
SCHF
$65.4B
| $28K | 0.02% |
1,266
+9
| +0.7% | +$187 |
|
99
Starbucks
SBUX
$124B
| $27.5K | 0.02% |
300
| – | – |
|
100
Public Service Enterprise Group
PEG
$39.6B
| $26.5K | 0.02% |
315
| – | – |
|
Similar funds
BRWM
SF
AC
HEM
EP
CF
TPBG
CFG
Syntax Research's Q2 2025 Portfolio in Review
As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.
- Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
- Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
- Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
- Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
- Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
- Syntax Research opened 7 new positions and closed 12 in Q2 2025.
- Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.
Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.